金尔康品牌怎么样 申请店铺

我要投票 金尔康在兽药行业中的票数:604 更新时间:2026-01-23
金尔康是哪个国家的品牌?「金尔康」是 河南金尔康动物药业有限公司 旗下著名品牌。该品牌发源于河南省郑州市,由创始人付 * 勤在2015年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力金尔康品牌出海!将品牌入驻外推网,定制金尔康品牌推广信息,可以显著提高金尔康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

金尔康怎么样

金尔康动物药业于2015年2月4日在上股交挂牌上市,金尔康动物药业是一家集科研、生产、销售为一体的大型高科技、现代化、专业化的兽药企业,下设金尔康生物科技园、产品研发中心、生物添加剂厂、四大GMP生产基地、金尔康商学院、综合事务办公室、财务中心、物流配送中心、法律事务部等机构。拥有农业部GMP验收通过的现拥有粉剂、散剂、预混剂、添加剂、口服液、消毒剂(固体/液体)、大容量注射液、小容量注射液等12条生产线。

金尔康动物药业是行业内先组建产品研发中心后建设GMP生产基地的企业。

工程技术研究中心现拥有博士、研究生、制药学专家、药理学专家、病理学专家和动物营养学专家等四十余人,其中博士10人(含博士后2人),硕士9人,河南省科技驻场特派员1人,郑州市科技创新骨干4人。金尔康动物药业建立了与国内养殖集团的战略合作关系。

前进中金尔康公司秉承“以结果为导向,建设做事企业、品牌企业、和谐企业”的价值观和“诚信创业  理性决策智慧经营稳健发展”的经营理念,按照“一个中心两个基本点三个创新”的发展战略,以“打造中国动保行业具核心竞争力的品牌企业,实现金尔康事业做稳做强做久”为愿景,与员工、客户、社会各界关心金尔康事业发展的朋友共襄盛举。以勤劳、勇气和智慧挑战未来,打造中国动保行业具核心竞争力的品牌企业,实现金尔康事业做稳、做强、做久。


Jinerkang Animal Pharmaceutical Co., Ltd. was listed on the Shanghai Stock Exchange on February 4, 2015. Jinerkang Animal Pharmaceutical Co., Ltd. is a large-scale high-tech, modern and professional animal pharmaceutical enterprise integrating scientific research, production and sales. It consists of jinerkang Biotechnology Park, product R & D center, biological additive factory, four GMP production bases, jinerkang business school, general affairs office and financial center , logistics distribution center, legal affairs department, etc. It has 12 production lines including powder, powder, premix, additive, oral liquid, disinfectant (solid / liquid), large volume injection, small volume injection and so on, which have passed the GMP acceptance of the Ministry of agriculture. Jinerkang animal pharmaceutical industry is an enterprise that first establishes a product R & D center and then builds a GMP production base. The engineering technology research center now has more than 40 people, including doctors, postgraduates, pharmacists, pharmacologists, pathologists and animal nutrition experts, including 10 doctors (including 2 postdoctors), 9 masters, 1 Resident Commissioner of science and technology in Henan Province, and 4 backbone of science and technology innovation in Zhengzhou city. Jinerkang animal pharmaceutical industry has established a strategic cooperation relationship with the domestic breeding group. Jinerkang company adheres to the values of "result oriented, building enterprises, brand enterprises and harmonious enterprises" and the business philosophy of "integrity, entrepreneurship, rational decision-making, intelligent management and steady development", and in accordance with the development strategy of "one center, two basic points and three innovations", to "build a brand enterprise with core competitiveness in China's mobile insurance industry and realize jinerkang's business With the vision of "stable, strong and long-term development of the industry", we will join hands with our employees, customers and friends from all walks of life who are concerned about the development of jinerkang's business. Challenge the future with diligence, courage and wisdom, build a brand enterprise with core competitiveness in China's mobile insurance industry, and realize the stable, strong and long-term development of jinerkang's business.

本文链接: https://brand.waitui.com/817defd10.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

2分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

2分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

2分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

2分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

2分钟前

本页详细列出关于金尔康的品牌信息,含品牌所属公司介绍,金尔康所处行业的品牌地位及优势。
咨询